The cash flow of Organon & Co. over the past 7 years
Chart Organon & Co.: operating cash flow, capital expenditures, free cash flow, fiscal 2019–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Organon & Co.'s operating cash flow was $700M and its capital expenditures $162M, leaving free cash flow of $538M. Free cash flow was above zero in all 7 years shown. It ranged from $538M in fiscal 2025 to $2.93B in fiscal 2019. Capital expenditures were highest in fiscal 2020, at $255M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $700M | $162M | $538M |
| 2024ended Dec 31, 2024 | $939M | $175M | $764M |
| 2023ended Dec 31, 2023 | $799M | $251M | $548M |
| 2022ended Dec 31, 2022 | $858M | $196M | $662M |
| 2021ended Dec 31, 2021 | $2.16B | $192M | $1.97B |
| 2020ended Dec 31, 2020 | $2.28B | $255M | $2.03B |
| 2019ended Dec 31, 2019 | $3.02B | $92M | $2.93B |
Fiscal years as Organon & Co. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Organon & Co.
- The revenue of Organon & Co.
- The profitability of Organon & Co.
- The debt of Organon & Co.
- The dividends of Organon & Co.
- All of Organon & Co.'s financials, charted
Companies of a similar size
- SEBSeaboard Corporation
- BFAMBRIGHT HORIZONS FAMILY SOLUTIONS INC.
- MSGEMADISON SQUARE GARDEN ENTERTAINMENT CORP.
- CDNACAREDX, INC.
- NICNICOLET BANKSHARES, INC
Not investment advice. This page shows what Organon & Co. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.